4.5 Review

Alternative clinical specimens for the detection of SARS-CoV-2: A rapid review

期刊

REVIEWS IN MEDICAL VIROLOGY
卷 31, 期 4, 页码 -

出版社

WILEY
DOI: 10.1002/rmv.2185

关键词

coronavirus; covid-19; diagnostics; nasal; nasopharyngeal; review; saliva; SARS-CoV-2

类别

资金

  1. Health Technology Assessment and Health Information and Standards Directorates at HIQA
  2. Health Research Board [HRB-CICER-2016-1871]

向作者/读者索取更多资源

This review synthesized evidence comparing the detection of SARS-CoV-2 RNA using saliva or nasal specimens with nasopharyngeal specimens. While alternative clinical specimens may offer benefits, the results showed inconsistencies and limited evidence for their use as viable alternatives.
The collection of nasopharyngeal swabs to test for the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an invasive technique with implications for patients and clinicians. Alternative clinical specimens from the upper respiratory tract may offer benefits in terms of collection, comfort and infection risk. The objective of this review was to synthesise the evidence for detection of SARS-CoV-2 ribonucleic acid (RNA) using reverse transcription polymerase chain reaction (RT-PCR) tested saliva or nasal specimens compared with RT-PCR tested nasopharyngeal specimens. Searches were conducted in PubMed, Embase, Europe PMC and NHS evidence from December 2019 to 20 July 2020. Eighteen studies were identified; 12 for saliva, four for nasal and two included both specimen types. For saliva-based studies, the proportion of saliva samples testing positive relative to all positive samples in each study ranged from 82.9% to 100%; detection in nasopharyngeal specimens ranged from 76.7% to 100%; positive agreement between specimens for overall detection ranged from 65.4% to 100%. For nasal-based studies, the proportion of nasal swabs testing positive relative to all positive samples in each study ranged from 81.9% to 100%; detection in nasopharyngeal specimens ranged from 70% to 100%; positive agreement between specimens for overall detection ranged from 62.3% to 100%. The results indicate an inconsistency in the detection of SARS-CoV-2 RNA in the specimen types included, often with neither the index nor the reference of interest detecting all known cases. Depending on the test environment, these clinical specimens may offer a viable alternative to standard. However, at present the evidence is limited, of variable quality, and relatively inconsistent.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据